Supplemental Information: OLIE, ITCC-082: A phase 2 trial of lenvatinib plus ifosfamide and etoposide in relapsed/refractory osteosarcoma.docx
收藏NIAID Data Ecosystem2026-03-12 收录
数据链接:
官方服务:
资源简介:
Supplemental Information - Definitions of study endpoints and relevant details
创建时间:
2021-08-12




